{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=5", "query": { "intervention": "standard of care treatment", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 9574, "total_pages": 958, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-13T07:30:36.152Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05627960", "title": "First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Triple Negative Breast Cancer", "Hormone-Resistant Breast Cancer", "Non Small Cell Lung Cancer", "Mesothelioma" ], "interventions": [ { "name": "AG-01 Compound", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "A&G Pharmaceutical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2022-02-14", "completion_date": "2026-11", "has_results": false, "last_update_posted_date": "2022-11-28", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05627960" }, { "nct_id": "NCT01303458", "title": "Addressing Low-Income Families' Basic Social Needs at Pediatric Visits", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Low Income Families Basic Social Needs" ], "interventions": [ { "name": "Basic Needs Surveillance (BNS) protocol", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Boston Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 336, "start_date": "2011-01", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2017-01-05", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 9, "location_summary": "Boston, Massachusetts • Dorchester, Massachusetts • Roslindale, Massachusetts + 2 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Dorchester", "state": "Massachusetts" }, { "city": "Dorchester", "state": "Massachusetts" }, { "city": "Dorchester", "state": "Massachusetts" }, { "city": "Dorchester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01303458" }, { "nct_id": "NCT03895138", "title": "Trial to Investigate the in Silico Optimization of Insulin Treatments", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Bypass" ], "interventions": [ { "name": "Standard Glucommander Protocol (SGP)", "type": "OTHER" }, { "name": "Optimized Glucommander (OGM)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 35, "start_date": "2018-03-19", "completion_date": "2019-04-30", "has_results": false, "last_update_posted_date": "2019-03-29", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03895138" }, { "nct_id": "NCT07547878", "title": "Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes" ], "interventions": [ { "name": "Finerenone", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Lotensin", "type": "DRUG" }, { "name": "Capoten", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" }, { "name": "Monopril", "type": "DRUG" }, { "name": "Lisinopril", "type": "DRUG" }, { "name": "Univasc", "type": "DRUG" }, { "name": "Aceon", "type": "DRUG" }, { "name": "Accupril", "type": "DRUG" }, { "name": "Altace", "type": "DRUG" }, { "name": "Mavik", "type": "DRUG" }, { "name": "Edarbi", "type": "DRUG" }, { "name": "Atacand", "type": "DRUG" }, { "name": "Avapro", "type": "DRUG" }, { "name": "Cozaar", "type": "DRUG" }, { "name": "Benicar", "type": "DRUG" }, { "name": "Micardis", "type": "DRUG" }, { "name": "Diovan", "type": "DRUG" }, { "name": "Invokana", "type": "DRUG" }, { "name": "Farxiga", "type": "DRUG" }, { "name": "Jardiance", "type": "DRUG" }, { "name": "Ertugliflozin", "type": "DRUG" }, { "name": "Brenzavvy", "type": "DRUG" }, { "name": "Sotagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 64, "start_date": "2026-04-30", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "Temple, Texas", "locations": [ { "city": "Temple", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07547878" }, { "nct_id": "NCT07265843", "title": "Fibrinogen in Liver Transplant", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Liver Transplant Surgery" ], "interventions": [ { "name": "Intercept Fibrinogen Complex (IFC)", "type": "BIOLOGICAL" }, { "name": "Cryoprecipitate Antihemophilic Factor (AHF)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Trauma Hemostatis and Oxygenation Research (THOR) Network", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2026-01-01", "completion_date": "2028-03-01", "has_results": false, "last_update_posted_date": "2025-12-05", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07265843" }, { "nct_id": "NCT07155174", "title": "A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Small Cell Lung Cancer" ], "interventions": [ { "name": "ABBV-706", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Lurbinectedin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2025-11-25", "completion_date": "2031-09", "has_results": false, "last_update_posted_date": "2026-10-02", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 12, "location_summary": "New Haven, Connecticut • Gainesville, Florida • Ocala, Florida + 9 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07155174" }, { "nct_id": "NCT05192590", "title": "Establishing Clinical Utility Evidence for Chronic Disease Management Testing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiometabolic Syndrome" ], "interventions": [ { "name": "Educational Materials and Chronic Disease Management Test (CDMT)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Qure Healthcare, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 247, "start_date": "2021-10-22", "completion_date": "2023-02-22", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05192590" }, { "nct_id": "NCT07435610", "title": "Acupuncture Therapy for Pediatric Disorders of Gut-Brain Interaction", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Disorders of Gut-brain Interaction" ], "interventions": [ { "name": "Active Therapeutic acupuncture intervention", "type": "OTHER" }, { "name": "Sham therapeutic acupuncture treatment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital of Orange County", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "8 Years to 17 Years" }, "enrollment_count": 96, "start_date": "2026-01-08", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "Irvine, California", "locations": [ { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07435610" }, { "nct_id": "NCT05041426", "title": "Letermovir for CMV Prevention After Lung Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Transplant", "CMV" ], "interventions": [ { "name": "Letermovir", "type": "DRUG" }, { "name": "Valganciclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fernanda P Silveira, MD, MS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 15, "start_date": "2021-12-06", "completion_date": "2025-03-03", "has_results": true, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05041426" }, { "nct_id": "NCT01652768", "title": "PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Malignant Brain Tumors" ], "interventions": [ { "name": "Research Questionnaires", "type": "OTHER" }, { "name": "Palliative Care Team", "type": "OTHER" }, { "name": "Educational Information Session for Patients and Caregivers", "type": "OTHER" }, { "name": "Contact every 2 weeks", "type": "OTHER" }, { "name": "Follow-up Surgical Visit Session", "type": "OTHER" }, { "name": "Medical and/or Radiation Oncology Appointment Session", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2011-12", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2013-08-29", "last_synced_at": "2026-10-13T07:30:36.152Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01652768" } ] }